181 related articles for article (PubMed ID: 8216687)
1. Antibody feedback regulation in MRL/lpr mice.
Heyman B; Gustavsson S; Kusakari C; Nose M; Kinoshita T; Klareskog L; Tarkowski A
J Autoimmun; 1993 Aug; 6(4):437-48. PubMed ID: 8216687
[TBL] [Abstract][Full Text] [Related]
2. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
[TBL] [Abstract][Full Text] [Related]
3. Abnormal behavior of gamma-committed B lymphocytes probed by a lymphocyte blastogenesis inhibitory factor in autoimmune MRL mice.
Sugimura K; Wada Y; Kimura T; Ohno T; Kobayashi S; Azuma I
Eur J Immunol; 1990 Sep; 20(9):1899-904. PubMed ID: 2209696
[TBL] [Abstract][Full Text] [Related]
4. Defective antigen-receptor-mediated regulation of immunoglobulin production in B cells from autoimmune strains of mice.
Anderson CC; Cairns E; Rudofsky UH; Sinclair NR
Cell Immunol; 1995 Aug; 164(1):141-9. PubMed ID: 7634346
[TBL] [Abstract][Full Text] [Related]
5. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
Seaman WE; Wofsy D; Greenspan JS; Ledbetter JA
J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
[TBL] [Abstract][Full Text] [Related]
6. Suppressor T-cell activity in MRL/Mp-lpr/lpr mice: differential effects on primary and memory antibody responses of MRL/Mp-lpr/lpr and MRL/Mp-+/+ spleen cells to thymus dependent and thymus independent antigens in vitro.
Wilson DA
Cell Immunol; 1985 Dec; 96(2):312-26. PubMed ID: 2943418
[TBL] [Abstract][Full Text] [Related]
7. Follicular dendritic cell dysfunction and disorganization of lymphoid structures in MRL/lpr mice.
Masuda A; Kasajima T
Lab Invest; 1999 Jul; 79(7):849-57. PubMed ID: 10418825
[TBL] [Abstract][Full Text] [Related]
8. Unique surface phenotype of T cells in lymphoproliferative autoimmune MRL/Mp-lpr/lpr mice.
Takei F
J Immunol; 1984 Oct; 133(4):1951-4. PubMed ID: 6332141
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antigen-specific T cell responses in autoimmune MRL/Mp-lpr/lpr and MRL/Mp-+/+ mice.
Scott CF; Tsurufuji M; Lu CY; Finberg R; Sy MS
J Immunol; 1984 Feb; 132(2):633-9. PubMed ID: 6197469
[TBL] [Abstract][Full Text] [Related]
10. Suppression of antigen-specific interleukin 2 production in the MRL/MpJ-lpr/lpr mouse.
Naides SJ
J Immunol; 1986 Jun; 136(11):4113-21. PubMed ID: 2422273
[TBL] [Abstract][Full Text] [Related]
11. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
12. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.
Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD
J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128
[TBL] [Abstract][Full Text] [Related]
13. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
[TBL] [Abstract][Full Text] [Related]
14. Nephritogenicity of the lprcg gene on the MRL background.
Kimura M; Ogata Y; Shimada K; Wakabayashi T; Onoda H; Katagiri T; Matsuzawa A
Immunology; 1992 Jul; 76(3):498-504. PubMed ID: 1526655
[TBL] [Abstract][Full Text] [Related]
15. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo.
Thyphronitis G; Kinoshita T; Inoue K; Schweinle JE; Tsokos GC; Metcalf ES; Finkelman FD; Balow JE
J Immunol; 1991 Jul; 147(1):224-30. PubMed ID: 1828822
[TBL] [Abstract][Full Text] [Related]
16. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
17. Repeated 0.5-Gy gamma irradiation attenuates autoimmune disease in MRL-lpr/lpr mice with suppression of CD3+CD4-CD8-B220+ T-cell proliferation and with up-regulation of CD4+CD25+Foxp3+ regulatory T cells.
Tago F; Tsukimoto M; Nakatsukasa H; Kojima S
Radiat Res; 2008 Jan; 169(1):59-66. PubMed ID: 18159952
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
[TBL] [Abstract][Full Text] [Related]
19. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
Kobayashi K; Hamano T; Kakishita E
Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
[TBL] [Abstract][Full Text] [Related]
20. Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras.
Sobel ES; Kakkanaiah VN; Schiffenbauer J; Reap EA; Cohen PL; Eisenberg RA
J Immunol; 1998 Feb; 160(3):1497-503. PubMed ID: 9570572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
